RSS

Karolinska Institutet

Morphogenesis — Florida-based immunotherapy company — and the Cell and Gene Therapy Group at Karolinska Institutet (KI) in Sweden have announced a collaboration for the development of targeted immunotherapies to treat cancer. more

News

Karolinska Institute spin out company, Pelago Bioscience, has entered into a strategic research collaboration and licence agreement with AstraZeneca for the further advancement of the CETSA method and its use in pre-clinical discovery more

News

Results from a new register-based study have suggested that blood-thinning drugs not only reduce the risk of stroke in patients with atrial fibrillation (AF) but also significantly reduces the risk of dementia in these patients. more

News

A study from Karolinska Institutet has shown that existing drugs used for treating tuberculosis can strengthen the immune system. more

News

Scientists have shown that hereditary angioedema type III — a rare and serious disorder, characterised by painful swellings in the skin and other organs — is caused by a defective blood protein, coagulation factor XII. more

News

Recipharm Venture Fund, Östersjöstiftelsen and Praktikerinvest have jointly invested kr28 million in Pharmanest. Recipharm’s part of the investment is kr8 million. more

News

A research laboratory dedicated to congenital metabolic diseases research has been formed by Karolinska Institutet and Max Planck Society. more

News

Cancer researchers and immunologists at Sweden’s Karolinska Institutet have now discovered how cancer cells can infiltrate the lymphatic system by ‘disguising’ themselves as immune cells. more

News

Inhalation Sciences Sweden, a portfolio company of Karolinska Development, has received US Patent Approval for its flagship technology the PreciseInhale system. more

Technology